The commercialization of industrial biotechnology is not as fast as we expected. Originally, we believe that production of bulk chemicals including biofuels, polymeric materials and chemical agents using microorganisms or enzymes will provide low cost, environmentally friendly products to partially replace petro-chemicals products \[[@B1]\]. However, this looks not so easy to materialize due to the facts that:

1\. Petroleum does not rise in price too much after 2008 financial crisis, other alternative energy sources, especially shale gas, natural gas hydrate (or gas hydrate) and sand oil, have been discovered in large amount and their exploitations are increasingly moving toward a very competitive price;

2\. The exhaustion of petroleum seems to be a remote reality

3\. Agriculture raw materials for bioprocessing are becoming increasingly costly

4\. Low cost raw material cellulose can not be easily used for microbial processes at least for the next 5--10 years

5\. Bioprocessing is still not as effective as chemical processing, resulting in high cost of bio-products (Table [1](#T1){ref-type="table"})

6\. Bioprocessing that requires large amount of fresh water has had increasing concerns in many water shortage areas

7\. The chemical industry is also evolving competitive in various ways including environmentally friendliness, the use of renewable resources (biomass) for making chemicals that are normally derived from petro-chemicals

8\. The rapid development of C1 chemical engineering products

9\. Large amount of funding is not more directed to industrial biotechnology.

###### 

Comparison of industrial biotechnology and chemical technology

  **Items**                              **Industrial biotechnology**                              **Chemical technology**
  -------------------------------------- --------------------------------------------------------- -----------------------------------------
  Reaction Time                          Slow: production takes days                               Fast: production takes hours
  Substrates                             Agricultural products                                     Petroleum or its derivatives
  Conversion of substrates to products   Low: e.g. PHB/glucose ≈ 33 wt% PHA/fatty acids ≈ 60 wt%   High: e.g. Polyethylene/ethylene ≈ 100%
  Medium                                 Water                                                     Mostly organic solvents
  Consumption of water                   A lot                                                     Less
  Reaction conditions                    30-40°C, normal pressure                                  Generally \>100°C, High Pressures
  Product concentration                  Low: Several mg to 100 g/L                                Very high
  Product recovery cost                  Very high                                                 Low to medium
  Processing                             Normally discontinuous one                                Can be continuous
  Sterilization                          Necessary                                                 No need
  Production facility cost               Very high                                                 Low to high (explosive proof)
  Waste water                            Not toxic, easier to treat                                Generally toxic, difficult to treat

Taking the example of polyhydroxyalkanoates (PHA), a biopolyester family that has been exploited to become an industrial value chain \[[@B2]-[@B4]\], PHA has not been able to commercially produce in large scale due to the difficulty to lower the production cost especially for their applications as bioplastics that are considered as biodegradable and bio-based despite the possibility of using CO~2~ as substrate \[[@B5]\].

To successfully commercialize PHA, we must keep working hard on the "high volume and low price" strategy by developing better PHA production strains and cost competitive processes. While for some special applications, "low volumes and high price" can be applied, such as products to be used for biomedical purposes, specialty polymers \[[@B6],[@B7]\], chiral monomers, drug development and special applications et al. \[[@B8],[@B9]\]. And this is generally true in order to survive this competitive environment for industrial biotechnology, it must be competitive with the chemical industry. Let's see what we can do to make this happen. In addition, it is also important to be able to develop processes that combined the advantages of chemical industry to supplement the weaknesses of industrial biotechnology (Table [1](#T1){ref-type="table"}).

The newly emerging synthetic biology approaches may offer some clues for developing competitive technology for industrial biotechnology to produce "high volume and low price" products (Table [2](#T2){ref-type="table"}). At the same time, bio-processing should try to become as similar as the chemical industry, including the need to develop continuous and open fermentation processes for e.g. making biofuels and PHA bioplastics \[[@B10]-[@B12]\]. Also, from now and toward a distant future, foods are still important for feeding the world population, the development of bioprocesses based on kitchen waste or activated sludge as substrates may also be an important option for a competitive industrial biotechnology (Table [2](#T2){ref-type="table"}).

###### 

Problems to be solved for making industrial biotechnology competitive to chemical technology

  **Problems**                                **Weakness of Industrial biotechnology**                         **Possible solutions**
  ------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------------------
  Microorganisms grow too slow                Slow: production takes days                                      Minimizing the microbial cells
  Microbes can not use mixed substrates       Agricultural products are mostly mixed substrates                Assembling pathways that can metabolize mixed substrates
  Low conversion of substrates to products    Cell metabolism turn substrates into CO~2~, H~2~O & byproducts   Removing unnecessary pathways consuming substrates
  High Consumption on fresh H~2~O             Fresh H~2~O as medium et al.                                     Utilization of sea water for cell growth
  Microbial cells grow to very low density    Product concentration low: Several mg to 100 g/L                 Minimizing oxygen demand for aerobic cells & reducing Quorum sensing effects
  Discontinuous processing                    Contamination concerns                                           Developing continuous process
  Sterilization costs high                    High pressed steam                                               Contamination resisting strains grown in open systems
  High energy demand for intensive aeration   Aerobic microorganisms need a lot of oxygen for growth           Developing anaerobic bioprocesses
  Difficulty to control the bio-processes     Complicated cellular metabolisms                                 Artificial cells that contain only necessary metabolic pathways
  One product by one microbial organism       Different organism has different strength.                       Development of a platform organism for many products
  Organisms consume food related products     Food for Fuels (Chemicals)                                       Kitchen wastes or activated sludge as substrates
  Production facility costly                  Costly materials and sensors                                     The use of carbon steel facilities et al.

Combination of bio- and chemical processes can offer a lot of advantages including bio-based (CO~2~ reduction) and fast reaction. Typical example includes the bio-production of lactic acid from anaerobic fermentation that is very effective and has only one single lactic acid product, and chemical polymerization of lactide to polylactide (PLA), a biodegradable green plastic \[[@B2],[@B13]\]. The PLA story is a successful combination of bio- and chemical advantages. Others like succinic acid and 1,4-butanol bio-production and their copolymerization are under intensive R&D \[[@B2],[@B13]\]. However, at the end, commercial successes have to be dependent on economy.
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